There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

The US Food and Drug Administration has approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with ...

Low climate-impact corticosteroid inhalers are as effective as high climate impact inhalers for COPD and asthma outcomes, per ...

It has been cleared for adults with uncontrolled COPD with raised blood eosinophils, a biomarker for type 2 inflammation ... of action in the next year or two after Amgen and AstraZeneca’s ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

Dupilumab, an injectable interleukin (IL)-4 and IL-13 pathway inhibitor, recently received FDA approval as the first-ever ...

An important part of the immune system, eosinophils are a type of white blood cell ... Dupixent Reduced Moderate to Severe COPD Exacerbations in Clinical Trials In two late-stage clinical trials ...

Learn how dupilumab significantly improves quality of life in COPD patients with type 2 inflammation, according to phase 3 ...

Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and ...